A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

12 May 2022

Generics companies are exploring new ways to increase access to medicine

Generic medicine manufacturers play a vital role in making essential health products available and accessible. But in a changing global health la...

01 Mar 2022

Three ways to fix healthcare supply chains and improve global health security

The global supply of essential medicines and vaccines is currently highly vulnerable to disruption. To address this urgent problem, the Access to Medi...

24 Feb 2022

As the pandemic passes, has progress been made on access to medical oxygen?

As the world moves forward from the pandemic, an integrated solution is still needed to address chronic problems with medical oxygen supply that preda...

10 Jan 2022

Foundation to deepen its work moving pharma companies on access to diabetes care

Each year, more than 100,000 children and young adults are diagnosed with type 1 diabetes. Although the products that can keep them alive do exist, th...

14 Dec 2021

Taking access to the next level: mobilising five essential healthcare sectors

With a new strategic direction for 2022-2026, the Access to Medicine Foundation will be expanding the range of companies and healthcare sectors which...

03 Dec 2021

Jane Masiga and Patrick Flochel bring breadth of experience as new Supervisory Board members

Jane Masiga and Patrick Flochel have joined the Supervisory Board of the Access to Medicine Foundation, in two significant appointments that will help...

13 Jul 2021

7 lessons from COVID-19 for pharma companies

There is a long way to go to curb the COVID-19 pandemic. To speed the end of the pandemic, and support a recovery that leaves no-one behind, the Acces...

16 Jun 2021

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries

Two of the world’s largest medical oxygen suppliers have agreed to work with the COVID-19 Oxygen Emergency Taskforce to increase access to medical oxy...

23 Feb 2021

Investors issue urgent call for “fair and equitable” global response to COVID-19

Today, almost 150 institutional investors have issued a joint call for a fair and equitable global response to the pandemic, including through fully f...

26 Jan 2021

Now online: 2021 Access to Medicine Index

Pharma companies move to systematically make new medicines rapidly accessible to the poor. The 2021 Access to Medicine Index identifies eight pha...

24 Nov 2020

The materiality of superbugs: risks and opportunities for pharma investors from antimicrobial resistance

Investors are starting to forecast a post-pandemic world. As part of these efforts, it is crucial that they understand and manage the risks of antimic...

23 Nov 2020

First investor partners named in joint initiative against 'super-sized' AMR threat

As World Antimicrobial Awareness Week begins, 12 global investors and financial institutions have announced they are joining the Investor Action on AM...

20 Nov 2020

Sharing surveillance data: the value of collaboration in curbing the next pandemic

Monitoring the spread of infectious diseases through surveillance programmes is fundamental to maintaining good public health and a key component of s...

20 Oct 2020

Bridging the gap in access to oxygen: Foundation coordinates on key actions for industry

Oxygen is critical in the treatment of pneumonia, which claims the lives of more than 672,000 children under 5 every year. Further, one in five COVID-...

06 Oct 2020

2021 Benchmark framework to track pharma's progress against superbugs

The rise of treatment-resistant bacterial and fungal diseases poses a direct threat both to modern medicine and our way of living. The Antimicrobial R...

02 Oct 2020

Which information matters most? Transparency by Pharma that builds access to medicine plus trust and engagement

The world depends on the pharmaceutical industry for life-saving medicines and vaccines yet trust in the industry is low. Pharmaceutical companies hav...

Back to top |